Idaho Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Pfizer, Inc. (NY: PFE)
28.95 USD  -0.02 (-0.05%)
Streaming Delayed Price  /  Updated: 12:42 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Pfizer, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stocks To Watch For April 30, 2013
April 30, 2013
Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer (NYSE: PFE ) to report its Q1 earnings at $0.56 per share on revenue of $14.00 billion. Pfizer shares rose 0.07% to... Read More
category Earnings , Benzinga , HLF , and 10 more.
from Latest Articles from Benzinga.com
Institutional Trading Activity Report for Pfizer (PFE)
April 30, 2013
NEW YORK (AVAFIN) -- Block trades help investors understand the sentiment of large financial ... Read More
from AVAFIN
Trading Radar for 04/30: Pfizer (PFE), Cummins (CMI), McGraw-Hill (MHP), DreamWorks (DWA), Sirius (SIRI) Report
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8286850 for the full story. Read More
from StreetInsider.com News Articles
Weekly Earnings Calendar: Social Media Stocks Report
April 29, 2013
This earnings week has plenty of appeal for the new generation. Some of the most prominent social media companies – Facebook (NASDAQ: FB) and LinkedIn (NASDAQ: LNKD) , namely – report. But there’s... Read More
from Wyatt Investment Research
Market Wrap for Monday, April 29: Stocks Start Week With a Rally
April 29, 2013
The S&P 500 traded into record high territory on Monday as the markets started the week off on a strong note. A rally in U.S. stocks was sparked in part by better than expected consumer spending for... Read More
category Earnings , Benzinga , Movers , and 30 more.
from Latest Articles from Benzinga.com
What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
April 29, 2013
 Read More
category NYSE:JNJ , NYSE:MRK , NYSE:PFE , and 2 more.
from Forbes Real Time
UPDATE 1-Merck, Pfizer to jointly develop diabetes drug
April 29, 2013
April 29 (Reuters) - Pfizer Inc and Merck & Co Inc said they will co-develop Pfizer's experimental type 2 diabetes drug ertugliflozin, both as a standalone product and in combination with other drugs,... Read More
category companyNews
from Reuters: Company News
Gain In Consumer Spending Boosts Markets
April 29, 2013
The markets extended its gains during the midday with the Dow soaring 93 points to 14,806 as March consumer spending rose 0.2%. Nasdaq gained 33 points to 3312. Read More
category Market News
from MarketMinute.com Market Updates
Top Undervalued Pharma Stock: Analyst
April 29, 2013
One biotech company has greater upside potential for 2013 than any other, pharmaceutical analyst Barbara Ryan says. Read More
category tvfmwebex , Fast Money Halftime Report , Valeant Pharmaceuticals International , and 12 more.
from CNBC.com News
Cramer: This Market Wants to Go Higher
April 29, 2013
If economic reports being released this week are positive, the market may climb for the rest of the year as cheap money drives investments, CNBC's Jim Cramer says. Read More
category Walt Disney Co , Apple Inc , tvcodes/tvearn , and 13 more.
from CNBC.com News
Oh, Come On: Pharma Whinges About Government Drug Sales Force.
April 29, 2013
The Daily Caller, the website founded and edited by libertarian Tucker Carlson, has found a new complaint among big pharma executives. The Obama administration’s “academic detailing” program — through... Read More
category NYSE:MRK , NYSE:PFE , NYSE:BMY
from Forbes Real Time
Agenus 8 Near term Data Drivers with a Market Opportunity over $17 Billion dollars
April 29, 2013
category Pharmaceuticals
from Trefis
Merck (MRK), Pfizer (PFE) Enter Ertugliflozin Development Agreement
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8284269 for the full story. Read More
from StreetInsider.com News Articles
RPT-Senator Paul stirs business ire over blocking of U.S. tax treaties
April 29, 2013
WASHINGTON, April 28 (Reuters) - Senator Rand Paul is coming under pressure from some multi-national businesses to drop his opposition to tax treaties between the United States and other nations. Read More
category companyNews
from Reuters: Company News
Earnings Expectations for the Week of April 29
April 28, 2013
First-quarter results from General Motors (NYSE: GM ) will be one of the highlights on the earnings front this week. Analysts anticipate that the carmaker will say Thursday its revenue slipped about... Read More
category Earnings , MSO , K , and 73 more.
from Latest Articles from Benzinga.com
A Look Ahead: This Week's ETFs to Watch
April 28, 2013
Last week was another fine one for U.S. stocks as the broader market fought off an array of data points that can only be considered mixed at best to again close higher. With last week's 1.4 percent... Read More
category Earnings , Specialty ETFs , Emerging Market ETFs , and 24 more.
from Latest Articles from Benzinga.com
Senator Paul stirs business ire over blocking of U.S. tax treaties
April 28, 2013
WASHINGTON, April 28 (Reuters) - Senator Rand Paul is coming under pressure from some multi-national businesses to drop his opposition to tax treaties between the United States and other nations. Read More
category companyNews
from Reuters: Company News
Pfizer Presents Phase 3 Prevenar 13 Data
April 28, 2013
Pfizer Inc. (NYSE: PFE ) presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Data to overtake earnings as May looms
April 28, 2013
Stocks have fared well after another earnings season of lowered expectations, but expect economic data and central-bank policy to take on more influence as the market begins to enter its softer... Read More
category Earnings , VIA , Banks , and 31 more.
from MarketWatch
Fed May Provide a Safety Net for the Market
April 26, 2013
The Fed is expected to repeat its dovish message in the coming week, which could provide a safety net for the market amid a big wave of earnings and the important April jobs report. Read More
category Realogy Corp , Archer Daniels Midland Co , tvcodes/tvearn , and 94 more.
from CNBC.com News
Jim Cramer: Mid-Week Sell-Off Potential Ahead
April 26, 2013
Next week investors could find themselves somewhat battered and bruised. Cramer sees the potential for problems around Wednesday. Read More
category Tanger Factory Outlet Centers Inc , tvcodes/tvpol , Buffalo Wild Wings Inc , and 35 more.
from CNBC.com News
Weekly Preview: Focus Shifts from Earnings to Economy
April 26, 2013
In the upcoming week, the focus of markets will gradually shift from earnings to the economy, especially later in the week, as key reports including the ECB rate decision and the U.S. Non-Farm Payrolls... Read More
category Rate Cuts , Earnings , Global , and 72 more.
from Latest Articles from Benzinga.com
Earnings Preview: Media Giants in the Spotlight
April 26, 2013
We're heading into the end of the heavy period of earnings season. Next week more than a quarter of the S&P 500 is set to report, including big names in media. Read More
category tvcodes/tvnn , tvcodes/tvearn , Merck & Co Inc , and 40 more.
from CNBC.com News
The Markets Now: Stocks Pull Back After GDP, Consumer Sentiment Reports
April 26, 2013
Plus, George Soros revealed that he owns a stake in JC Penney. Read More
category AMZN , AAPL , PFE , and 1 more.
from Minyanville Headlines
UPDATE 3-AbbVie delivers on strong growth of Humira arthritis drug
April 26, 2013
April 26 (Reuters) - AbbVie Inc's quarterly profit rose 10 percent on surging sales of its Humira treatment for rheumatoid arthritis, and the company said it plans to launch several potentially... Read More
category companyNews
from Reuters: Company News
Cardio Drugs Can Weigh On Pfizer’s Results
April 26, 2013
category Pharmaceuticals
from Trefis
Humira Still Abbvie Story With Pipeline Chapter Ahead
April 26, 2013
In its first quarter as a standalone pharmaceutical company, AbbVie (ABBV) delivered as promised robust growth from its Humira biologic for myriad autoimmune diseases while Wall Street awaits some key... Read More
category NYSE:ABBV , NYSE:PFE , NYSE:ABT , and 1 more.
from Forbes Real Time
StreetInsider.com Pre-Open Movers 4/26: (AVNR) (DHI) (FB) Higher; (PKI) (BIDU) (GNC) Lower (more...)
April 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8281876 for the full story. Read More
from StreetInsider.com News Articles
Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner
April 26, 2013
category Pharmaceuticals , Internet
from Trefis
Market Wrap: Options on the Fritz; Yahoo! Chair Ducks Out; JCPenney Finds Hope...in Soros
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8280834 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here